GM-CSF-expressing Oncolytic Vaccinia Virus Western Reserve (ΔK3L), pSL-GMCSF(Cat#: CyOV-0095WQ)

This product is a GM-CSF expressing oncolytic vaccinia virus, which is based on VACV-WR with K3L deleted.The GM-CSF is a monomeric glycoprotein that functions as a cytokine-it is a white blood cell growth factor.The deletion of K3L and GM-CSF expression could enhance the immune activity. This product can be used in oncolytic virotherapy research and vaccinie application.

Specifications

Family Poxviridae
Species Vaccinia virus
Serotype Western Reserve
Backbone VACV-WR(ΔK3L)
Backbone Background VACV-WR strain derived from Wyeth through passaging in mice and shown high tumor selectivity and strong oncolytic effect in mouse models.The engineered VACV-WR could further enhance the immune activity and the efficacy of cancer therapies.
Gene Modification ΔK3L
Promoter pSL
Transgene GM-CSF
Type of Transgene Cytokine
Related Target/Protein Granulocyte-macrophage colony-stimulating factor
Capsid Modification None
Titer >1*10^8 PFU
Related Diseases Melanoma, Breast Cancer

Transgene

Alternative Names CSF2; GMCSF
Gene ID 100137216
UniProt ID P04141

Information

Introduction Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.

Customer Reviews and Q&As

There are currently no customer reviews or questions for GM-CSF-expressing Oncolytic Vaccinia Virus Western Reserve (ΔK3L), pSL-GMCSF (CyOV-0095WQ). Click the button below to contact us or submit your feedback about this product.

All products and services are for Research Use Only. Not For Clinical Use.

Other products

PRODUCTS

Online Inquiry